Adaptive partial drug approval: A health policy proposal

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

Charles Manski of Northwestern argues that the drug approval process should be more continuous, so that patients can have access to beneficial drugs earlier and at the same time there are incentives for longer term studies than the current system produces, which could limit problems like those caused by Vioxx.

Original languageEnglish (US)
Article numberA9
JournalEconomists' Voice
Volume6
Issue number4
DOIs
StatePublished - 2009

Keywords

  • Clinical trials
  • Diversification
  • Food and Drug Administration

ASJC Scopus subject areas

  • Business, Management and Accounting(all)
  • Economics, Econometrics and Finance(all)

Fingerprint Dive into the research topics of 'Adaptive partial drug approval: A health policy proposal'. Together they form a unique fingerprint.

Cite this